-+ 0.00%
-+ 0.00%
-+ 0.00%

ALA files IND with the U.S. FDA for phase 1 clinical trial

ASX·12/30/2025 01:20:06

The content of this announcement was automatically generated by machine and is for reference only. The original announcement can be viewed by clicking on the link below.